Versant Ventures' biotech incubation team has launched another Swiss startup, this time focused on a pair of antibodies for ...

Sales of Merck’s HPV vaccine plummeted 41% in the first quarter, as the company continues to deal with lower demand in China.

Roche details plans to handle US tariffs, including moving production and building inventory, while Sanofi runs scenarios but ...

But the company is not ruling out future deals, even in its metabolic unit, which recently saw a major partnership with ...

Pfizer, Novartis, Amgen, Eli Lilly and J&J lead pharma lobbying spend amid policy changes. Issues include 340B program, drug ...

As­traZeneca CEO Pas­cal So­ri­ot called on Eu­rope to step up in­vest­ments and “pro­tect its health sov­er­eign­ty” as it ...

Sanofi reports Q1 growth with Altuviiio sales doubling to €251M and Dupixent reaching €3.5B; company terminates two cancer trials while focusing on immunology leadership ...

The FDA has asked Novavax to commit to producing post-marketing data of its Covid vaccine, the clearest example yet that the ...

Eli Lilly on Wednesday filed lawsuits against four telehealth companies over their sale of compounded versions of the GLP-1 ...

A Bay Area protein design startup wants to build more potent antibody-drug conjugates, and is starting with $20 million in ...

Ascletis Pharma's obesity drug ASC30 shows puzzling results in Phase 1b trial, with high dose less effective than lower doses ...

Repertoire Immune Medicines makes a major announcement in April. And this year is no different. The Flagship ...